Plants and phytochemicals for Huntington's disease
Sunayna Choudhary1, Puneet Kumar2, Jai Malik1
1Department of Pharmacognosy, ISF College of Pharmacy, Moga, Punjab, India.
This review explores natural treatments for Huntington's disease (HD), a neurodegenerative disorder. It highlights plants and phytochemicals that may alleviate HD symptoms and offers insights into the disease's pathophysiology.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Huntington's disease (HD) is a progressive neurodegenerative disorder affecting striatal and cortical neurons.
- Pathogenesis involves genetic factors, oxidative stress, excitotoxicity, and mitochondrial dysfunction.
- Current treatments manage chorea but do not halt disease progression.
Purpose of the Study:
- To review the pathophysiology of Huntington's disease.
- To identify plants and phytochemicals with potential therapeutic effects on HD symptoms.
- To consolidate existing literature on natural interventions for HD.
Main Methods:
- Comprehensive literature search across major scientific databases (PubMed, Scopus, Google Scholar, etc.).
- Defined search strategy to identify relevant studies on HD pathophysiology and natural treatments.
- Review and synthesis of collected data on plants and phytochemicals.
Main Results:
- Multiple hypotheses explain HD pathogenesis, including genetic and metabolic factors.
- Several plants and phytochemicals demonstrate potential in alleviating HD-like symptoms in preclinical studies.
- Evidence suggests natural compounds may target pathways involved in neuronal dysfunction in HD.
Conclusions:
- Natural products offer a promising avenue for managing Huntington's disease symptoms.
- Further research into specific phytochemicals and their mechanisms is warranted.
- Integrative approaches combining conventional and natural therapies may benefit HD patients.
More Related Videos
07:08Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
Related Concept Videos
Huntington Disease l: Introduction
Cancer Prevention
Some...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Pharmacogenomics: Identification of New Drug Targets
Plant Hormones
Defenses Against Pathogens and Herbivores
